SI-BONE, Inc. to Report Q3 2024 Financial Results
SI-BONE, Inc. (NASDAQ: SIBN), renowned for its innovative solutions in treating sacropelvic disorders, has announced that it will share its third-quarter financial results soon. This anticipated report is set to be released after the market closes on a specified Tuesday.
Conference Call Details
In conjunction with the financial report, SI-BONE will host a conference call, allowing investors and interested parties to gain real-time insights. The call will begin at a late afternoon time, aligning with both Pacific and Eastern Time zones.
Innovations in Sacropelvic Surgery
As a leader in medical technology, SI-BONE has made significant contributions to the field, focusing specifically on minimally invasive procedures for sacropelvic disorders. Since the introduction of its pioneering techniques in 2009, the company has empowered thousands of surgeons worldwide, contributing to over 100,000 successful procedures.
Clinical Evidence Supporting SI-BONE Technologies
SI-BONE's advancements are backed by a robust foundation of clinical data. To date, there are two crucial randomized controlled trials and more than 135 peer-reviewed publications validating the effectiveness of its technology. This body of evidence underscores the reliability of SI-BONE's innovations in patient care.
Expanding Product Offerings
Beyond sacropelvic disorders, SI-BONE continues to innovate by exploring adjacent markets. The company has expanded its portfolio to include solutions for adult deformities, spinopelvic fixation, and pelvic trauma, positioning itself as a comprehensive resource for complex surgical solutions.
Investor Information
For those interested in learning more about SI-BONE’s offerings, including potential risks and benefits, additional information is readily available on its corporate website. SI-BONE encourages stakeholders to stay informed regarding their latest developments and product insights.
Contact Information
For investor-related inquiries, SI-BONE invites you to reach out to Saqib Iqbal. Contact can be made through the provided email, where further questions regarding the upcoming report and corporate developments can be addressed.
Frequently Asked Questions
What is the date of SI-BONE's Q3 2024 financial results report?
SI-BONE plans to report its financial results on a specific Tuesday after market close.
How can I access the conference call?
Investors can register for the conference call through SI-BONE's investor relations page.
What is the focus of SI-BONE, Inc.?
SI-BONE focuses on developing innovative medical solutions for the surgical treatment of sacropelvic disorders.
What supporting information exists for SI-BONE's technologies?
The company has over 135 peer-reviewed publications and two randomized controlled trials supporting its work.
Who should I contact for investor inquiries?
Investors can contact Saqib Iqbal via email for any inquiries related to SI-BONE and its financial results.